Aperio VERSA - Visikol's Highly Multiplexed Immunohistochemistry Approach to Drug Discovery
Visikol is a biotechnology company focused on advanced imaging, digital pathology, and 3D cell culture assays that has developed a unique imaging platform that allows for 10+ plex immunofluorescent slide imaging. Through this presentation, Visikol will provide a background on various multiplex tissue imaging approaches and will describe how they can be used to answer complex research questions such as surveying the immune cell population within a tumor microenvironment, or evaluating therapeutics for infectious diseases. Specifically, Visikol will discuss how its proprietry multiplex approach has been leveraged through a partnership with Hackensack Meridian Health (HMH) to evaluate tuberculosis treatments. This work is funded by the Bill & Melinda Gates Foundation using Visikol’s multiplex approach combined with several imaging modalities to evaluate treatments using a multi-modal imaging approach.
- Develop an understanding of multiplex slide labeling and imaging techniques.
- Demonstrate a working knowledge of the multiple types of multiplex tools available for whole slide imaging.
- Identify the unique types of research questions that can be addressed through multiplex imaging.
For research use only. Not for use in diagnostic procedures.
For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted. Leica Biosystems and the editors hereby disclaim any liability arising directly or indirectly from the use of the content, including from any drugs, devices, techniques or procedures described in the content.
Copyright © 2021 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.